Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Griffin P Rodgers

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
JAMA|August 9, 2020
Precision Nutrition-the Answer to "What to Eat to Stay Healthy"Griffin P Rodgers, Francis S Collins
JAMA|September 9, 2020
Obesity and Hypertension in the Time of COVID-19Griffin P Rodgers, Gary H Gibbons
Annals of Internal Medicine|January 6, 2017
Glycemic Therapy for Type 2 Diabetes: Choices Expand, Data Lag BehindJudith E Fradkin, Griffin P Rodgers
Experimental Hematology|August 17, 2004
Inhibition of beta protein 1 expression enhances beta-globin promoter activity and beta-globin mRNA levels in the human erythroleukemia (K562) cell lineOlga P Zoueva, Griffin P Rodgers
Cell Metabolism|February 13, 2021
COVID-19 and metabolic diseases: a heightened awareness of health inequities and a renewed focus for research prioritiesWilliam T Cefalu, Griffin P Rodgers
The Lancet. Global Health|March 16, 2023
Indigenous and minority groups in diabetes trialsDavid R Wilson, Griffin P Rodgers
JAMA|September 20, 2012
The next generation of obesity research: no time to wasteGriffin P Rodgers, Francis S Collins
Diabetes Care|August 27, 2024
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study: Continuing to Build on 40 Years of Diabetes ResearchWilliam T Cefalu, Griffin P Rodgers
Diabetes|January 26, 2013
Diabetes research: a perspective from the National Institute of Diabetes and Digestive and Kidney DiseasesJudith E Fradkin, Griffin P Rodgers
British Journal of Haematology|June 25, 2015
HbA2 : biology, clinical relevance and a possible target for ameliorating sickle cell diseaseMartin H Steinberg, Griffin P Rodgers
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
JAMA|August 9, 2020
Precision Nutrition-the Answer to "What to Eat to Stay Healthy"Griffin P Rodgers, Francis S Collins
JAMA|September 9, 2020
Obesity and Hypertension in the Time of COVID-19Griffin P Rodgers, Gary H Gibbons
Annals of Internal Medicine|January 6, 2017
Glycemic Therapy for Type 2 Diabetes: Choices Expand, Data Lag BehindJudith E Fradkin, Griffin P Rodgers
Experimental Hematology|August 17, 2004
Inhibition of beta protein 1 expression enhances beta-globin promoter activity and beta-globin mRNA levels in the human erythroleukemia (K562) cell lineOlga P Zoueva, Griffin P Rodgers
Cell Metabolism|February 13, 2021
COVID-19 and metabolic diseases: a heightened awareness of health inequities and a renewed focus for research prioritiesWilliam T Cefalu, Griffin P Rodgers
The Lancet. Global Health|March 16, 2023
Indigenous and minority groups in diabetes trialsDavid R Wilson, Griffin P Rodgers
JAMA|September 20, 2012
The next generation of obesity research: no time to wasteGriffin P Rodgers, Francis S Collins
Diabetes Care|August 27, 2024
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study: Continuing to Build on 40 Years of Diabetes ResearchWilliam T Cefalu, Griffin P Rodgers
Diabetes|January 26, 2013
Diabetes research: a perspective from the National Institute of Diabetes and Digestive and Kidney DiseasesJudith E Fradkin, Griffin P Rodgers
British Journal of Haematology|June 25, 2015
HbA2 : biology, clinical relevance and a possible target for ameliorating sickle cell diseaseMartin H Steinberg, Griffin P Rodgers
Pageof 11